Antithrombotic Drugs Research Report 2023
DUBLIN, Aug. 4, 2023 /PRNewswire/ -- The "Antithrombotic Drugs Market By Drug Type , By Route of Administration, By Application, By End User, and Geography - Trend, Analysis, and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.
The global antithrombotic drugs market is set to experience substantial growth, with a predicted size of USD 105.33 billion by 2032
This expansion is driven by the increasing incidence of cardiovascular diseases, making it a significant concern for the forecast period. Factors such as the rising prevalence of cardiovascular illnesses, an aging population, and sedentary lifestyles are key drivers propelling the growth of the worldwide antiplatelet medicines market.
Cardiovascular diseases remain the leading cause of death in both developed and developing economies. For instance, data from the American Heart Association indicates that atrial fibrillation affected at least 3 to 6 million individuals in the United States in June 2018, with expectations of this number rising to 6 to 16 million by 2050.
Additionally, heart transplants are being carried out at significant rates, with states like California, Texas, Florida, and New York leading in the number of procedures. These factors contribute to the growing demand for antithrombotic and anticoagulant medications, as they become increasingly crucial in the management of cardiovascular illnesses and other thrombotic conditions.
The ongoing COVID-19 pandemic has also impacted the market, with research focused on evaluating the efficacy of antithrombotic medications in COVID-19 patients, and exploring parenteral administration techniques for critically ill patients.
With a favorable outlook and increasing demand, the antithrombotic drugs market is poised for substantial expansion in the coming years.
Antithrombotic Drugs Market Report Highlights
- Antiplatelet drugs are expected to dominate the market due to increasing use for clotting as arterial clots comprised primarily of platelets, antiplatelet medications are most effective.
- Activities by key players in the market for the development of antiplatelet drugs are expected to drive the market growth over the forecast period.
- Anticoagulant, Thrombolytic, and oral drugs is expected to hold the largest market share during the forecast period. Anticoagulants work by interfering with several blood coagulation pathways, making them closely connected to antiplatelet medications and thrombolytic therapies.
Market Dynamics
Drivers and Opportunities
- Increasing prevalence of chronic diseases
- Rising number geriatric population
Restraints and Challenges
- Side effects linked with antithrombotic drugs
Porter's Five Forces Analysis
PESTLE Analysis
Antithrombotic Drugs Industry Trends
Value Chain Analysis
COVID-19 Impact Analysis
Company Profiles
- Bristol-Myers Squibb Company
- AstraZeneca plc
- Eli Lilly and Company
- C.H. Boehringer Sohn AG & Ko. KG
- Aspen Bayer AG
- Pfizer
- Johnson & Johnson. AstraZeneca
- Otsuka Pharmaceutical
- Portola Pharmaceutical Inc.
- Yuyu Pharma Inc.
- Daiichi Sankyo Company
- Limited
- Glenmark Pharmaceuticals Limited
- China National Pharmaceutical Group Corp
- Novartis
- Acetlion Pharmaceuticals
- Generium Holdings
Scope of the Report
Antithrombotic Drugs market, By Drug Type (Revenue - USD Billion, 2019-2032)
- Antiplatelet Drug
- Anticoagulant Drug
- Thrombolytic Drug
Antithrombotic Drugs market, By Route of Administration (Revenue - USD Billion, 2019-2032)
- Oral
- Parenteral
Antithrombotic Drugs market, By Application (Revenue - USD Billion, 2019-2032)
- Pulmonary Embolism
- Deep Vein Thrombosis
- Atrial Fibrillation
- Others
Antithrombotic Drugs market, By End User (Revenue - USD Billion, 2019-2032)
- Hospitals
- Ambulatory Surgery Centres
- Emergency Service Centres
- Others
Antithrombotic Drugs market, Geography (Revenue - USD Billion, 2019-2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
For more information about this report visit https://www.researchandmarkets.com/r/2tgy9l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
Share this article